Background/Aims: Parkinson’s disease (PD) is a common neurodegenerative disease with a chronic disease course. The increase in life expectancy of humans worldwide is expected to increase the prevalence and duration of PD; therefore, it is important to determine factors that contribute to the caregiver burden for both clinical and social reasons. Methods: We surveyed 91 main caregivers of patients, and compared factors contributing to caregiver burden between 50 spouses and 41 offspring of patients. We determined Burden Interview, Depression Scale, Health-Related Quality of Life, and Obligation Scale scores, as well as the degree of functional social support of caregivers. Results: Interestingly, the burden scores of the two groups were not significantly different. Correlation analysis revealed that depression, health-related quality of life, social support, subdivided parts of the Unified Parkinson’s Disease Rating Scale (UPDRS), Hoehn and Yahr Scale, score of Mini-Mental State Examination, and Barthel index were correlated with burden in both spouses and offspring. However, in multiple regression, depression score and part 1 of the UPDRS were more significant predictors of burden in the spousal group, whereas social support of community and part 3 of the UPDRS were more important correlated factors in the offspring group. Conclusions: The caregiver burden of spousal and offspring caregivers of PD patients was not significantly different. However, different factors contributed to caregiver burden according to the caregiver’s relationship with the patient.

Keywords:
Caregiver burden predictors, Parkinson’s disease, Spouse, Offspring
1.
Schulz R, Beach SR: Caregiving as a risk factor for mortality: the caregiver health effects study. JAMA 1999;282:2215–2219.
2.
Pinquart M, Sorensen S: Differences between caregivers and noncaregivers in psychological health and physical health: a meta analysis. Psychol Aging 2003;18:250–267.
3.
Pinquart M, Sorensen S: Correlates of physical health of informal caregivers: a meta-analysis. J Gerontol Psychol Sci 2007;62:126–137.
4.
Aarsland D, Larsen JP, Karlsen K, Lim NG, Tandberg E: Mental symptoms in Parkinson’s disease are important contributors to caregiver distress. Int J Geriatr Psychiatry 1999;14:866–874.
5.
Dura JR, Haywood-Niler E, Kiecolt-Glaser JK: Spousal caregivers of persons with Alzheimer’s and Parkinson’s disease dementia: a preliminary comparison. Gerontologist 1990;30:332–336.
6.
Miller E, Berrios GE, Politynska BE: Caring for someone with Parkinson’s disease: factors that contribute to distress. Int J Geriatr Psychiatry 1996;11:263–268.
7.
O’Reilly F, Finnan F, Allwright S, Smith GD, Ben-Shlomo Y: The effects of caring for a spouse with Parkinson’s disease on social, psychological and physical well-being. Br J Gen Pract 1996;46:507–512.
8.
Zarit SH, Reever KE, Bach-Peterson J: Relatives of the impaired elderly: correlates of feelings of burden. Gerontologist 1980;20:649–655.
9.
Edwards NE, Scheetz PS: Predictors of burden for caregivers of patients with Parkinson’s disease. J Neurosci Nurs 2002;34:184–190.
10.
Secker DL, Brown RG: Cognitive behavioural therapy (CBT) for carers of patients with Parkinson’s disease: a preliminary randomized controlled trial. J Neurol Neurosurg Psychiatry 2005;76:491–497.
11.
Martınez-Martın P, Forjaz MJ, Frades-Payo B, Rusiñol AB, Fernández-Garcıa JM, Benito-León J, Arillo VC, Barberá MA, Sordo MP, Catalán MJ: Caregiver burden in Parkinson’s disease. Mov Disord 2007;22:924–931.
12.
Radloff LS: The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1997;1:385–401.
13.
The EuroQol Group: EuroQol – a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199–208.
14.
Cicirelli VG: Attachment and obligation as daughter’s motives for caregiving behavior and subsequent effect on subjective burden. Psychol Aging 1993;8:144–155.
15.
Sung KT: Measures and dimensions of filial piety in Korea. Gerontologist 1995;35:240–247.
16.
Lee J, Yoo MS, Jung D: Caregiving appraisal of family caregivers for older stroke patients in Korea. Int Nurs Rev 2010;57:107–112.
17.
McDowell I, Newell C: Measuring health, a guide to rating scales and questionnaires. Oxford, Oxford University Press, 1996.
18.
Sherbourne D, Stewart AL: The MOS Social Support Survey. Soc Sci Med 1991;32:705–714.
19.
Carter JH, Lyons KS, Stewart BJ, Archbold PG, Scobee R: Does age make a difference in caregiver strain? Comparison of young versus older caregivers in early-stage Parkinson’s disease. Mov Disord 2010;25:724–730.
20.
Happe S, Berger K: The association between caregiver burden and sleep disturbances in partners of patients with Parkinson’s disease. Age Ageing 2002;31:349–354.
21.
Schrag A, Hovris A, Morley D, Quinn N, Jahanshahi M: Caregiver-burden in Parkinson’s disease is closely associated with psychiatric symptoms, falls, and disability. Parkinsonism Relat Disord 2006;12:35–41.
22.
Habermann B, Davis LL: Caring for family with Alzheimer’s disease and Parkinson’s disease: needs, challenges and satisfaction. J Gerontol Nurs 2005;31:49–54.
23.
Glozman JM: Quality of life of caregivers. Neuropsychol Rev 2004;14:183–196.
24.
Chappell NL, Reid RC: Burden and well-being among caregivers: examining the distinction. Gerontologist 2002;42:772–780.
25.
Yates ME, Tennstedt S, Chang BH: Contributors to and mediators of psychological well-being for informal caregivers. J Gerontol B Psychol Sci Soc Sci 1999;54:12–22.
26.
Carter JH, Stewart BJ, Archbold PG, Inoue I, Jaglin J, Lannon M, Rost-Ruffner E, Tennis M, McDermott MP, Amyot D, Barter R, Cornelius L, Demong C, Dobson J, Duff J, Erickson J, Gardiner N, Gauger L, Gray P, Kanigan B, Kiryluk B, Lewis P, Mistura K, Malapira T, Pay M, Sheldon C, Winfield L, Wolfington-Shallow K, Zoog K: Living with a person who has Parkinson’s disease: the spouse’s perspective by stage of disease. Parkinson’s Study Group. Mov Disord 1998;13:20–28.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.